Frontiers in Fluorescence imaging: Tools for the In-Situ Sensing of Disease Biomarkers
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
A
comprehensive
overview
of
recent
advancements
in
fluorescence
imaging
techniques
for
situ
sensing
various
biomarkers,
emphasizing
the
transformative
potential
artificial
intelligence
shaping
future
bioimaging.
Language: Английский
Zero-Crosstalk Tumor-Targeting Ratiometric Near-Infrared γ-Glutamyltranspeptidase Probe for Fluorescent-Guided Surgical Resection of Orthotopic Hepatic Tumor
Zhichao Yang,
No information about this author
ZhiHao Yang,
No information about this author
Zhiqiang Wang
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
The
challenge
of
"false
positive"
signals
significantly
complicates
tumor
localization
and
surgical
resection,
which
are
pivotal
for
successful
surgeries.
Therefore,
the
development
a
method
preoperative
intraoperative
margin
determination
holds
considerable
promise
improving
outcomes.
In
this
study,
zero-crosstalk
ratiometric
tumor-targeting
near-infrared
(NIR)
fluorescent
probe
was
developed
precise
cancer
diagnosis
navigation
via
NIR
fluorescence
imaging.
This
integrates
moiety
that
selectively
homes
in
on
hepatocellular
carcinoma
cells
exhibits
highly
sensitive
response
to
γ-glutamyltranspeptidase
(GGT),
characterized
by
substantial
emission
shift
from
830
650
nm.
unique
property
enhances
its
effectiveness
early
imaging-guided
surgery
resection.
Furthermore,
successfully
monitors
GGT
activity
blood,
cells,
vivo,
endowing
potential
clinic.
Due
efficient
targeting
situ
both
subcutaneous
tumors
orthotopic
hepatic
tumors,
accurate
detection
capability
tumors.
Additionally,
leveraging
imaging,
can
serve
as
sprayable
tool
delineating
margins
with
precision,
thereby
furnishing
real-time
imaging
guidance
during
resection
surgery.
Language: Английский
A novel near-infrared fluorescent probe with large Stokes shift for monitoring γ-glutamyltranspeptidase in tumor and liver injury mice
Zhiqing Wang,
No information about this author
Juan Liu,
No information about this author
Zhi-Ke Tan
No information about this author
et al.
Microchemical Journal,
Journal Year:
2025,
Volume and Issue:
209, P. 112668 - 112668
Published: Jan. 4, 2025
Language: Английский
A Dual‐Response DNA Origami Platform for Imaging and Treatment of Sepsis‐Associated Acute Kidney Injury
Yingying Zhao,
No information about this author
Yadan Zhao,
No information about this author
Yufan Ling
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 28, 2025
Abstract
Current
diagnostics
for
sepsis‐associated
acute
kidney
injury
(SA‐AKI)
detect
damage
only
at
advanced
stages,
limiting
opportunities
timely
intervention.
A
DNA
origami‐based
nanoplatform
is
developed
the
early
diagnosis
and
treatment
of
SA‐AKI.
Modified
with
a
fluorophore
(Cy5)
quencher
(BHQ3),
origami
remains
nonfluorescent
under
normal
conditions.
During
SA‐AKI,
elevated
microRNA‐21
triggers
strand
displacement
reaction
that
restores
fluorescence
signal,
enabling
real‐time
detection.
Additionally,
photoacoustic
changes
BHQ3,
driven
by
different
excretion
rates
nanostructure
released
strands,
enable
dual‐mode
imaging,
enhancing
diagnostic
accuracy.
Therapeutically,
scavenges
reactive
oxygen
species
and,
when
conjugated
antimicrobial
peptide
Leucine‐Leucine‐37
(LL‐37),
exhibits
bactericidal
effects.
This
combination
boosts
survival
80%
in
SA‐AKI
models.
dual‐response
integrates
precise
imaging
targeted
therapy,
offering
powerful
strategy
management
advancing
applications
precision
nanomedicine.
Language: Английский
Dual-miRNA Guided in-vivo Imaging and Multimodal Nanomedicine Approaches for Precise Hepatocellular Carcinoma Differentiation and Synergistic Cancer Theranostics using DNA Hairpins and Dual-Ligand functionalized Zirconium-MOF Nanohybrids
Biomaterials,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123330 - 123330
Published: April 1, 2025
Language: Английский
Fluorescent probes in autoimmune disease research: current status and future prospects
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 9, 2025
Autoimmune
diseases
(AD)
present
substantial
challenges
for
early
diagnosis
and
precise
treatment
due
to
their
intricate
pathogenesis
varied
clinical
manifestations.
While
existing
diagnostic
methods
strategies
have
advanced,
sensitivity,
specificity,
real-time
applicability
in
settings
continue
exhibit
significant
limitations.
In
recent
years,
fluorescent
probes
emerged
as
highly
sensitive
specific
biological
imaging
tools,
demonstrating
potential
AD
research.This
review
examines
the
response
mechanisms
historical
evolution
of
various
types
probes,
systematically
summarizing
latest
research
advancements
application
autoimmune
diseases.
It
highlights
key
applications
biomarker
detection,
dynamic
monitoring
immune
cell
functions,
assessment
drug
efficacy.
Furthermore,
this
article
analyzes
technical
currently
encountered
probe
development
proposes
directions
future
research.
With
ongoing
materials
science,
nanotechnology,
bioengineering,
are
anticipated
achieve
higher
sensitivity
enhanced
functional
integration,
thereby
facilitating
monitoring,
innovative
Overall,
possess
scientific
significance
value
both
related
diseases,
signaling
a
new
era
personalized
precision
medicine.
Language: Английский
A Hydrogen Sulfide‐Activated NIR‐II Fluorescence/NIR‐I Photoacoustic Dual‐Ratiometric Nanoprobe With Unique Recognition Reaction for Precise Visual Diagnosis of Hepatitis Disease
Lixian Huang,
No information about this author
Fei Lv,
No information about this author
Yidong Bin
No information about this author
et al.
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Abstract
Hydrogen
sulfide
(H
2
S)
is
a
vital
gaseous
signaling
molecule
that
plays
central
role
in
various
physiological
and
pathological
processes.
Given
the
complementary
advantages
of
fluorescence
(FL)
photoacoustic
(PA)
imaging,
there
growing
demand
for
dual‐ratiometric
probes
enable
precise
vivo
monitoring
H
S
levels.
In
this
study,
use
2‐mercapto‐1,3,4‐thiadiazole
(MTD)
as
novel
recognition
group
presented
first
time,
following
conjugation
with
cyanine
dyes
to
obtain
new
PA
probe
Cy‐MTD.
To
achieve
Cy‐MTD
incorporated
into
down‐conversion
nanoparticle
(DCNP),
resulting
creation
pioneering
NIR‐II
FL/NIR‐I
nanoprobe
DCNP@Cy‐MTD.
undergoes
blueshift
absorption
from
840
670
nm
after
reaction
S,
enabling
NIR‐I
ratiometric
imaging
by
measuring
ratio
signal
at
(PA
/PA
).
addition,
due
strong
≈840
overlapping
between
spectrum
808
excitation
band
DCNP,
nm‐excited
FL
emission
(F
1550
nm,808Ex
)
DCNP
DCNP@Cy‐MTD
quenched
through
competitive
absorption,
while
it
restored
upon
interaction
because
Using
stable
under
980
nm,980Ex
reference
signal,
/F
achieved.
The
response
features
offer
significant
advancement
over
traditional
single‐signal
or
single‐modality
techniques.
By
providing
enhanced
accuracy
reliability,
allows
diagnosis
hepatitis
surpassing
capabilities
conventional
histopathological
methods,
which
provides
way
more
effective
diagnostic
strategies
liver
diseases.
Language: Английский